RXi Pharmaceuticals Announces Upcoming Presentations WESTBOROUGH, Mass.--(BUSINESS WIRE)--RXi Pharmaceuticals Corporation (OTC: RXII), a biotechnology company
News prior to or on 03-17-13
focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced upcoming presentations at AsiaTIDES and at the ROTH 25th Annual Conference. AsiaTIDES On Tuesday, February 26, 2013 at 9:40 am JST, Karen G. Bulock, Ph.D., Vice President of Research for RXi Pharmaceuticals will be participating in
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.